Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanil Bhatia

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Chemical Science|October 18, 2021
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profileChristoph Selg, Andrea Schöler, Julian Schliehe-Diecks, et al.
Journal of Medicinal Chemistry|October 27, 2018
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome InhibitorSanil Bhatia, Viktoria Krieger, Michael Groll, et al.
European Journal of Medicinal Chemistry|December 28, 2020
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitorsLeandro A Alves Avelar, Christian Schrenk, Melf Sönnichsen, et al.
Haematologica|April 16, 2026
Efficacy of the kinase inhibitor <i>CHZ868</i> against <i>JAK2</i> rearrangements in pediatric acute lymphoblastic leukemiaManuel Quadri, Claudia Saitta, Sonia Palamini, et al.
Chemmedchem|February 25, 2021
Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia ActivityMarc Pflieger, Melf Sönnichsen, Nadine Horstick-Muche, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2020
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)Laura Sinatra, Jan J Bandolik, Martin Roatsch, et al.
European Journal of Medicinal Chemistry|May 7, 2024
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Julian Schliehe-Diecks, Lukas von Bredow, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget DrugsLukas von Bredow, Thomas Martin Schäfer, Julian Hogenkamp, et al.
Journal of Medicinal Chemistry|August 18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping GroupsNina Reßing, Melf Sönnichsen, Jeremy D Osko, et al.
International Journal of Molecular Sciences|February 13, 2025
Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast CancerJasmin Linh On, Sahel Ghaderi, Carina Rittmann, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Chemical Science|October 18, 2021
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profileChristoph Selg, Andrea Schöler, Julian Schliehe-Diecks, et al.
Journal of Medicinal Chemistry|October 27, 2018
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome InhibitorSanil Bhatia, Viktoria Krieger, Michael Groll, et al.
European Journal of Medicinal Chemistry|December 28, 2020
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitorsLeandro A Alves Avelar, Christian Schrenk, Melf Sönnichsen, et al.
Haematologica|April 16, 2026
Efficacy of the kinase inhibitor <i>CHZ868</i> against <i>JAK2</i> rearrangements in pediatric acute lymphoblastic leukemiaManuel Quadri, Claudia Saitta, Sonia Palamini, et al.
Chemmedchem|February 25, 2021
Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia ActivityMarc Pflieger, Melf Sönnichsen, Nadine Horstick-Muche, et al.
Angewandte Chemie (International Ed. in English)|August 12, 2020
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)Laura Sinatra, Jan J Bandolik, Martin Roatsch, et al.
European Journal of Medicinal Chemistry|May 7, 2024
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabineMaik Tretbar, Julian Schliehe-Diecks, Lukas von Bredow, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget DrugsLukas von Bredow, Thomas Martin Schäfer, Julian Hogenkamp, et al.
Journal of Medicinal Chemistry|August 18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping GroupsNina Reßing, Melf Sönnichsen, Jeremy D Osko, et al.
International Journal of Molecular Sciences|February 13, 2025
Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast CancerJasmin Linh On, Sahel Ghaderi, Carina Rittmann, et al.
Pageof 6